Navigation Links
Drug May Shrink Fibroids, Preserve Fertility
Date:7/1/2010

THURSDAY, July 1 (HealthDay News) -- Preliminary research suggests that a new drug treatment shrinks uterine fibroids and helps women with the non-cancerous tumors retain their fertility.

Uterine fibroids, which cause abdominal pain and heavy menstrual bleeding, are a leading cause of hysterectomy. They can also contribute to miscarriage.

"Both the fibroids and the surgical interventions commonly used to treat them can cause significant fertility problems," Dr. Alicia Armstrong, chief of gynecologic services at the U.S. National Institutes of Health's Program for Reproductive and Adult Endocrinology, said in a news release.

In two new studies, researchers tested a drug called ulipristal acetate (also known as ellaOne), which blocks ovulation and is used as a form of emergency contraception. It works by adjusting the body's reaction to the hormone progesterone.

In the studies, 57 women aged 25-50 with uterine fibroids were randomly assigned to receive treatment with the drug or a placebo. They took the pills once a day for three menstrual cycles.

The fibroids shrank in more of those women who took the drug instead of the placebo, and those who took higher doses had better results. Women who took the drug also had less bleeding than those who took the placebo.

The studies show that the drug "is an effective non-invasive treatment for fibroids that can help maintain fertility in women whose only option up to now was to have surgery," Dr. Lynnette Nieman, a principal investigator with the studies, said in the news release issued by the European Society of Human Reproduction and Embryology.

The studies are both in Phase II, the second in three phases of research required before the federal government will approve a drug for a specific use.

In an interview, Dr. Scott Chudnoff, a gynecologist and uterine fibroid specialist, said the research could lead to significant new treatments for women with fibroids. But some women might not respond the same way to the treatment, and the fibroids may return when women stop taking the drug, said Chudnoff, director of gynecology at Montefiore Medical Center in New York City.

Still, a new treatment would help doctors do a better job of personalizing their approach to individual patients, he said. The research, he added, is "definitely promising."

The study findings were to be presented Wednesday at the annual meeting of the European Society of Human Reproduction and Embryology in Rome.

More information

For more about uterine fibroids, visit the U.S. National Library of Medicine.

-- Randy Dotinga

SOURCES: Scott Chudnoff, M.D., assistant professor, department of obstetrics & gynecology and women's health, Albert Einstein College of Medicine, and director of gynecology, Montefiore Medical Center, New York City; European Society of Human Reproduction and Embryology, news release, June 30, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. New lung cancer drug shows dramatic results for shrinking tumors
2. Virtual visits shrink the distance in stroke rehab
3. As girth grows, risk of sudden cardiac death shrinks
4. Drug for advanced kidney cancer shrinks tumors prior to surgery
5. Cognitive Skills May Shrink With Tamoxifen
6. GYN Oncologist Uses da Vinci Surgical Robot to Preserve Fertility
7. San Jose Parks Foundation Launches "ParkForce" Campaign to Protect and Preserve San Jose's Parks & Trails
8. Woodmeister Master Builders Announces Commitment to Preserve One Foot of Forest for Each Foot it Builds
9. Transplant drug preserves kidneys, avoids toxicity
10. Smell of old books offers clues to help preserve them
11. RESOLVE: The National Infertility Association Announces Partnership with Attain Fertility
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Drug May Shrink Fibroids, Preserve Fertility
(Date:8/19/2017)... ... August 19, 2017 , ... Praeclarus Press ... mothers. These illustrations show the diversity of the breastfeeding mothers, using bright ... range of sizes. These illustrations are also available on tote bags, notepads, smartphone ...
(Date:8/18/2017)... ... August 19, 2017 , ... Mr. Noppadon Pakprot, Deputy ... Amazing Thailand Health and Wellness Tourism Showcase 2017 yesterday, which unveiled the latest ... for Tourism Products and Business at TAT said, “Thailand has long been recognized ...
(Date:8/18/2017)... ... August 18, 2017 , ... August ... “Vision & Hearing,” advocating for active, healthy lifestyles and highlighting the importance of ... individuals with hearing impairments and shares the latest innovations in hearing aid technology. ...
(Date:8/18/2017)... (PRWEB) , ... August 18, 2017 , ... ... consulting services and asset protection assistance to communities in North-Central West Virginia, is ... critical services to at-risk boys in the area. , The Chestnut Mountain Ranch ...
(Date:8/18/2017)... ... 2017 , ... The Golseth Agency, a Texas based insurance management and financial ... regional charity campaign organized to provide support to Christina Upchurch and her two children ... and her children returned from out of town to find her husband passed away ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... Aug. 15, 2017   Mostyn Law and Gulf Coast ... Houston, Texas . The Mostyn Law family has ... years. That is why Mostyn Law is partnering with ... to show its appreciation. Blood supplies are running low. ... short of hospital needs in August. That is why the blood ...
(Date:8/15/2017)... N.C. , Aug. 15, 2017  Axium Pharmaceuticals Inc., the creator ... rumored to be in the beginning stages of an IPO. ... on epilepsy medications with the average cost of a prescription epilepsy drug ... ... Another staggering figure is the fact ...
(Date:8/15/2017)... , Aug. 15, 2017  AOTI Inc. announced today that its ... Inc., has recently opened a New York City Office in ... of its unique Topical Wound Oxygen (TWO 2 ) homecare therapy. ... Accreditation Commission for Health Care (ACHC) under the company,s DMEPOS accreditation ... ...
Breaking Medicine Technology: